Cannabidiol Modulates Hippocampal Glutamate Function
Comments Off on Cannabidiol Modulates Hippocampal Glutamate Function
April 25, 2026
A single dose of cannabidiol hippocampal glutamate modulation reduced abnormal brain activity during memory tasks in people at clinical high risk for psychosis. This suggests cannabidiol may normalize glutamate signaling in brain regions critical for…
Cannabidiol Clinical Trials: High Risk Psychosis Research
Comments Off on Cannabidiol Clinical Trials: High Risk Psychosis Research
April 22, 2026
Cannabidiol clinical trials reveal how a single dose of CBD affects hippocampal glutamate and brain activation in high risk psychosis. These trials suggest CBD's potential to normalize brain chemistry in early psychosis. Ongoing research aims to confirm…